Pharmacological treatment for psychotic depression

Pharmacological treatment for psychotic depression

Show other versions (2)

Detalhes bibliográficos
Main Authors:	Wijkstra, J, Lijmer, J, Burger, H, Cipriani, A, Geddes, J, Nolen, W
Formato:	Journal article
Publicado em:	Cambridge University Press 2018

Registos relacionados

Pharmacological treatment for psychotic depression.
Por: Wijkstra, J, et al.
Publicado em: (2013)

Pharmacological treatment for psychotic depression.
Por: Wijkstra, J, et al.
Publicado em: (2005)

Pharmacological treatment for psychotic depression: Cochrane systematic review and meta-analysis
Por: Wijkstra, J, et al.
Publicado em: (2005)

Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis.
Por: Wijkstra, J, et al.
Publicado em: (2006)

A genetic risk score to predict treatment nonresponse in psychotic depression
Por: Sophie E. ter Hark, et al.
Publicado em: (2024-03-01)

Correction: A genetic risk score to predict treatment nonresponse in psychotic depression
Por: Sophie E. ter Hark, et al.
Publicado em: (2024-04-01)

Predicting treatment outcome in depression: so far, so good.
Por: Cipriani, A, et al.
Publicado em: (2016)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
Por: Maria Gałuszko-Węgielnik, et al.
Publicado em: (2023-01-01)

Psychotic depression and deaths due to suicide
Por: Paljärvi, T, et al.
Publicado em: (2022)

Antidepressants for bipolar depression - Dr. Gijsman and colleagues reply
Por: Gijsman, H, et al.
Publicado em: (2005)

Psychotic depression and the risk of death due to suicide
Por: T. Paljarvi, et al.
Publicado em: (2023-03-01)

Depression in adults: drug and physical treatments.
Por: Cipriani, A, et al.
Publicado em: (2011)

Depression in adults: drug and physical treatments.
Por: Barbui, C, et al.
Publicado em: (2007)

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.
Por: Gijsman, H, et al.
Publicado em: (2004)

Long-term treatment of depression with antidepressants: a systematic narrative review.
Por: Furukawa, T, et al.
Publicado em: (2007)

Venlafaxine for major depression.
Por: Cipriani, A, et al.
Publicado em: (2007)

Suicide, depression, and antidepressants.
Por: Cipriani, A, et al.
Publicado em: (2005)

Treatment Options for Psychotic Depression in Adolescents: A Comprehensive Review
Por: Perez-Rodriguez V, et al.
Publicado em: (2025-01-01)

Is content of delusions in psychotic depression related to the risk of dementia?
Por: J. T. Coelho, et al.
Publicado em: (2024-04-01)

Mortality in psychotic depression: 18-year follow-up study
Por: Paljärvi, T, et al.
Publicado em: (2022)

Association of the neutrophil to lymphocyte ratio and white blood cell count with response to pharmacotherapy in unipolar psychotic depression: An exploratory analysis
Por: Cornelis F. Vos, et al.
Publicado em: (2021-10-01)

Post-psychotic depression: what are its characteristics?
Por: A. Abdelhamid, et al.
Publicado em: (2024-04-01)

Placebo for depression: we need to improve the quality of scientific information but also reject too simplistic approaches or ideological nihilism.
Por: Cipriani, A, et al.
Publicado em: (2014)

Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrumResearch in context
Por: Thuy-Dung Nguyen, et al.
Publicado em: (2025-02-01)

Lithium salts in the treatment of psychotic excitement
Por: John F. J. Cade
Publicado em: (2000-01-01)

Quantitative EEG (qEEG) in Patients with Bipolar Psychotic Depression and Unipolar Psychotic Depression under Electroconvulsive Therapy (ECT)
Por: Joana Bravo, et al.
Publicado em: (2023-01-01)

PSIKOSA DEPRESI REAKTIF(Psychotic Depressive Reaction)
Por: Perpustakaan UGM, i-lib
Publicado em: (1976)

Cotard's syndrome and major depression with psychotic symptoms
Por: Leonardo Machado, et al.
Publicado em: (2013-06-01)

Predicters of individual psychotic experiences after trauma: a series of longitudinal studies
Por: Geddes, G
Publicado em: (2018)

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
Por: María S. García-Gutiérrez, et al.
Publicado em: (2020-11-01)

Treatment of Depression With Psychotic Features in Maltreated Adolescents: Evidence-Based Case Report
Por: Feronia Augustine Setiawan, et al.
Publicado em: (2023-11-01)

Effect of lamotrigine in the treatment of bipolar depression with psychotic features: a case report
Por: Tomoko Kajiya, et al.
Publicado em: (2017-08-01)

Extrapyramidal syndrome in psychotic depression: a case report.
Por: C. Álvarez, et al.
Publicado em: (2023-03-01)

Pharmacological Treatments for Patients with Treatment-Resistant Depression
Por: Valerie L. Ruberto, et al.
Publicado em: (2020-06-01)

Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD ΙΙ
Por: Flint Alastair J, et al.
Publicado em: (2013-01-01)

Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis
Por: Cipriani, A, et al.
Publicado em: (2017)

Exploring resting state connectivity in patients with psychotic depression.
Por: Mardien L Oudega, et al.
Publicado em: (2019-01-01)

Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis
Por: Miura, T, et al.
Publicado em: (2014)

Depressive disorder needs an evidence base commensurate with its public health importance.
Por: Geddes, J, et al.
Publicado em: (2007)

Depressive disorders.
Por: Geddes, J, et al.
Publicado em: (2004)